Skip Navigation U.S. Department of Health and Human Services www.hhs.gov/
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov/
Diabetes Planned Visit Notebook

Blood Pressure Titration Protocol Flow Sheet


Diabetes planned visits address several health topics of concern to the diabetic patient, including high blood pressure. This document provides guidance for prescribing medication to control blood pressure.


Blood Pressure Titration Protocol

Name:   _____________________________      Chart# ______________  PCP: _______________________

Date protocol initiated: ______________            Baseline BP: _________/_________

BP goal: ___ <130/70 ___ <125/70 (microalbumin, nephropathy) ___ other ____________________________

Baseline Creatinine _______________               Estimated GFR: ________________

Physician/NP Notification Parameters

Systolic BP    <_______(100)   >_________(180)        Serum Na  <______(130)  >________(147)

Diastolic BP   <_______(50)     >_________(110)       Serum K  >5.0   <3.5

Apical pulse   <_______(50-60) >_________(100)       Serum creatinine >30% above baseline ________

Physician/NP Orders

Diagnosis: ___ HTN__ DM-uncontrolled

Medication:  ______________________________     Dose Initiated:  __________________________

Increase dosage according to BP titration protocol to: Target dose _______     Maximum dose  __________

Nurse visit for BP, HR, Review for Adverse effects  Q _________________ BMP Q ____________________

Other: __________________________________________     Signature: __________________

Date

Medication

Current dose

SBP

DBP

Apical

Lab Date

Na

K

Cr

Adverse Effects

Dose change

Initials

                   

see back

   
                         
                         
                         

___ Continue current plan
___ Discontinue protocol                                                               Physician/NP signature: ________________________________________________

Date

Medication

Current dose

SBP

DBP

Apical

Lab Date

Na

K

Cr

Adverse Effects

Dose change

Initials

                   

see back

   
                         
                         
                         

___ Continue current plan
___ Discontinue protocol                                                               Physician/NP signature: ________________________________________________

Have you experienced any new or worsening:

___ = YES    If Yes, describe below                                    ___ = NO

Date

           

Weakness

                   

Swelling

                   

Wheezing

                   

Cough

                   

Shortness of breath

                   

Constipation

                   

Nausea

                   

Fatigue

                   

Palpitations

                   

Insomnia

                   

Nightmares

                   

Coolness of hands/feet

                   

Headache

                   

Dizziness

                   

Rash

                   

Initials

                   

Describe:

__________________________________________________________________________________________________________________

__________________________________________________________________________________________________________________

__________________________________________________________________________________________________________________

__________________________________________________________________________________________________________________

__________________________________________________________________________________________________________________

__________________________________________________________________________________________________________________

__________________________________________________________________________________________________________________

Return to Diabetes Planned Visit Notebook Contents
Proceed to Next Section

 

AHRQAdvancing Excellence in Health Care